News

Using robotic devices during gait training can improve walking abilities in people with multiple sclerosis (MS), particularly among those with severe disability, a review of 17 studies has found. However, the benefits lasted only a few months, suggesting that patients need regular training to maintain the improvements. The study,…

A single dose of NVG-291, a potential nerve repair therapy for multiple sclerosis (MS), was safe and well-tolerated among healthy volunteers in a Phase 1 safety trial, and was found to have favorable pharmacological properties, new data show. Given the positive results thus far, a safety committee supervising…

Extracellular vesicles or EVs — tiny sacs of material excreted by cells — that have been coated with protein receptors were found to safely reduce disease progression in a mouse model of multiple sclerosis (MS). Researchers at the Karolinska Institutet, in Sweden, coated these vesicles with receptors that block pro-inflammatory…

Numares has signed an exclusive licensing agreement with Oxford University Innovation to develop and commercialize a panel of biomarkers that identify disease progression in people with multiple sclerosis (MS). Specifically, the company aims to create a tool that detects early signs of conversion from relapsing remitting…

Acthar Gel (repository corticotropin injection) was found to be a cost-effective treatment for people with multiple sclerosis (MS) experiencing a relapse, according to an economic analysis. Notably, the economic value of Acthar Gel was greater than that of alternative treatments — plasmapheresis and intravenous immunoglobulin — from the…

There is no link between serum vitamin D levels and the age at which an individual develops the first symptoms of multiple sclerosis (MS), a new observational study suggests. However, a link was found between cerebrospinal fluid antibody levels, serum vitamin D levels, and the age at first MS…

Mindfulness-based interventions (MBIs) helped people with multiple sclerosis (MS) cope with symptoms, and many said they would recommend these practices to others living with MS, according to a review of published studies related to patients’ experiences. The participants reported the benefits of a shared experience, but stressed the importance…

Not drinking alcohol significantly increases the risk of developing multiple sclerosis (MS), especially if a person also is a current or former smoker, according to a new study. These findings add to the knowledge, discovered in multiple previous studies, that alcohol decreases the activity of the immune system. According…

The injectable ACTH gel medication Cortrophin Gel (repository corticotropin injection), first introduced in the U.S. in the 1950s, will now be relaunched as a treatment for acute flare-ups in multiple sclerosis (MS) and other autoimmune conditions, following its approval by the U.S. Food and Drug Administration (FDA). In…

A new podcast series hosted and produced by cultural expert Jess Weiner aims to help girls, non-binary individuals, and women, with their confidence. The target audience includes those with physical disorders, such as multiple sclerosis (MS), that may affect their self-image. Called “Dominant Stories with Jess Weiner,” the 12-episode…

The COVID-19 pandemic brought extra strain to already-stretched neurology services across the U.K., markedly affecting multiple sclerosis (MS) care and patients’ health, according to a report from the MS Society. These findings were consistent with those of a 2020 report from U.K.’s Neurological Alliance showing that the pandemic…

Tri Global Energy, an ongoing supporter of the National Multiple Sclerosis Society’s Dallas chapter, will be the title sponsor of one of the society’s premier fundraising events, “Dallas On the Move Luncheon.” The Dallas-based company, which specializes in renewable energy and energy storage, signed the sponsorship with a…

This year’s Women Against Multiple Sclerosis (WAMS) Gala, which aims to raise funds for multiple sclerosis (MS) research, will take place Nov. 5. In order to keep participants safe in the setting of the ongoing pandemic, the MS Society of Canada‘s initiative will feature three events held virtually:…

New preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of multiple sclerosis (MS). In a collaboration with its academic partner, the Medical University of Vienna, Cyxone has shown that a combination of T20K plus an activator of the kappa…

People who contract infectious mononucleosis — colloquially known as “mono” — during childhood or adolescence are at a roughly two to three times greater risk of developing multiple sclerosis (MS) as adults, a large population-based study suggests. Notably, the study points to mono itself — independent of other factors…

A musical about the life of St. Frances Xavier Cabrini, the Italian-born Roman Catholic nun known as Mother Cabrini to the many immigrants in New York she served in the late 19th and early 20th centuries, tells Cabrini’s story through the eyes of a 13-year-old girl with multiple sclerosis (MS)…

Colder ambient temperatures may ease the inflammation that drives multiple sclerosis (MS), early research in a mouse model suggests. Animals whose environment for two weeks was set at 10 C (about 50 F) had a “pronounced attenuation” of disease severity and other benefits compared with those kept at a…

Owlytics Healthcare, in partnership with Tel-Aviv Medical Center in Israel, has taken its smartwatch — designed to monitor symptoms of multiple sclerosis (MS) from afar — through a first stage of validation. The smartwatch, worn on the wrist, collects a continuous stream of personal health data that are sent to…

Into-the-vein treatment with mesenchymal stem cells (MSCs) failed to significantly reduce brain inflammation or improve clinical conditions among adults with active multiple sclerosis (MS) in an international Phase 2 clinical trial, according to final study data. The trial, which used magnetic resonance imaging (MRI) scans to assess…

The National Multiple Sclerosis Society is accepting submissions for funding of new researcher-initiated proposals that help advance multiple sclerosis (MS) research and care in line with its Pathways to Cures Roadmap — to stop the disease in its tracks, restore what has been lost, and find a…

Black and Hispanic/Latinx people with multiple sclerosis (MS) in the U.S. tend to have more severe disease, but less access to specialty care, greater diagnostic delays, and poorer outcomes, a review found. Moreover, Blacks are at higher risk than whites of both developing MS and dying from it. These…

A model that considers changes in brain volume and serum neurofilament (sNfL) levels during the early stages of multiple sclerosis may help clinicians to determine an individual’s likely progression with relapsing forms of MS, a study suggests. “We were able to build reliable, robust models capable of accurate predictions of…

The main character of a new, five-issue reprise of the original “Darkhawk” Marvel comic battles crime while navigating his way through being newly diagnosed with multiple sclerosis (MS). Connor Young, a 17-year-old high school senior and basketball star, has his life turned upside down with this news, when he…

The National Multiple Sclerosis Society supports the use of a patient-derived bone marrow transplant to treat people with very aggressive relapsing-remitting multiple sclerosis (RRMS) who responded poorly to disease-modifying therapies (DMTs). This position is in line with a recent set of society recommendations on how and in…

The Adira Foundation received nearly $750,000 from the Bristol Myers Squibb Foundation to improve care and access for the roughly 5,000 multiple sclerosis (MS) patients living in rural areas of Maryland, North Carolina, Virginia, and West Virginia. Intended to enhance the access and delivery of specialized care to…

The Multiple Sclerosis Association of America (MSAA) is calling for submissions for its 2022 MSAA Art Showcase, an initiative that celebrates the work of artists who have multiple sclerosis (MS). The showcase, which began in 2009, gives MS patients in the U.S. the opportunity to share their…

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Four…

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Certain types of…

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. In people with progressive multiple sclerosis (MS), neuron loss…

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Lesions…